Pelvic exenteration for recurrent or persistent gynecologic malignancies: A 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981) Journal Article
| Authors: | Lawhead, R. A. Jr; Clark, D. G. C.; Smith, D. H.; Pierce, V. K.; Lewis, J. L. Jr |
| Article Title: | Pelvic exenteration for recurrent or persistent gynecologic malignancies: A 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981) |
| Abstract: | From January 1, 1972 to December 31, 1981, sixty-five patients underwent pelvic exenteration as treatment for recurrent or persistent gynecologic malignancy at Memorial Sloan-Kettering Cancer Center. Cervical carcinoma was the disease most commonly treated by exenteration. The operative mortality of 9.2% represents an improvement over previous reports from this institution. After routine use of prophylactic minidose heparin, no cases of thrombophlebitis or pulmonary embolus occurred postoperatively. A 5-year survival rate of 23% warrants continued use of exenteration in carefully selected patients. The significant mortality and morbidity associated with pelvic exenteration preclude its use as a palliative procedure. © 1989. |
| Keywords: | retrospective studies; major clinical study; mortality; review; cancer recurrence; pelvis; ovarian neoplasms; neoplasm recurrence, local; morbidity; genital neoplasms, female; remission induction; uterine cervix carcinoma; vulva carcinoma; vagina carcinoma; evisceration; hemorrhage; pelvic exenteration; human; female; priority journal; intestinal fistula |
| Journal Title: | Gynecologic Oncology |
| Volume: | 33 |
| Issue: | 3 |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 1989-06-01 |
| Start Page: | 279 |
| End Page: | 282 |
| Language: | English |
| DOI: | 10.1016/0090-8258(89)90512-x |
| PUBMED: | 2722049 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work